Outcomes and prognostic factors in patients with synchronous endometrial and ovarian cancer

  • 0Department of Obstetrics and Gynecology, Peking University People's Hospital, Peking University, Beijing, 100044, China.

|

|

Summary

This summary is machine-generated.

Synchronous endometrial and ovarian cancer (SEOC) survival is impacted by advanced ovarian cancer stage and platinum resistance. Tailored treatments and closer monitoring are crucial for platinum-resistant SEOC patients.

Area Of Science

  • Gynecologic Oncology
  • Clinical Cancer Research
  • Translational Medicine

Background

  • Synchronous endometrial and ovarian cancer (SEOC) presents a unique clinical challenge.
  • Understanding prognostic factors is crucial for optimizing patient outcomes in SEOC.

Purpose Of The Study

  • To identify prognostic factors influencing survival in SEOC patients.
  • To analyze survival outcomes and guide clinical management strategies for SEOC.

Main Methods

  • Retrospective cohort study of 64 SEOC patients (2004-2024).
  • Analysis of clinicopathological data, progression-free survival (PFS), and overall survival (OS).
  • Multivariate analysis to determine independent prognostic factors.

Main Results

  • Vaginal bleeding was the most common symptom; endometrioid carcinoma was the most frequent histology.
  • Median PFS was 27 months and median OS was 41 months.
  • Advanced ovarian FIGO stage predicted worse PFS; platinum resistance was linked to reduced OS (P=0.002).

Conclusions

  • Platinum sensitivity was observed in 67.9% of SEOC cases.
  • Advanced ovarian cancer stage and platinum resistance are independent predictors of poor survival.
  • Tailored therapeutic strategies and intensified surveillance are needed for platinum-resistant SEOC.